Correlation Between US Global and Lipocine
Can any of the company-specific risk be diversified away by investing in both US Global and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining US Global and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US Global Investors and Lipocine, you can compare the effects of market volatilities on US Global and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in US Global with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of US Global and Lipocine.
Diversification Opportunities for US Global and Lipocine
Good diversification
The 3 months correlation between GROW and Lipocine is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding US Global Investors and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and US Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US Global Investors are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of US Global i.e., US Global and Lipocine go up and down completely randomly.
Pair Corralation between US Global and Lipocine
Given the investment horizon of 90 days US Global Investors is expected to under-perform the Lipocine. But the stock apears to be less risky and, when comparing its historical volatility, US Global Investors is 4.09 times less risky than Lipocine. The stock trades about -0.03 of its potential returns per unit of risk. The Lipocine is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 466.00 in Lipocine on October 4, 2024 and sell it today you would earn a total of 20.00 from holding Lipocine or generate 4.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
US Global Investors vs. Lipocine
Performance |
Timeline |
US Global Investors |
Lipocine |
US Global and Lipocine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with US Global and Lipocine
The main advantage of trading using opposite US Global and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if US Global position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.US Global vs. Gladstone Investment | US Global vs. PennantPark Floating Rate | US Global vs. Horizon Technology Finance | US Global vs. Stellus Capital Investment |
Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |